Shenzhen Chipscreen Biosciences Co.,Ltd. Posted 35.8 Million Yuan Net Loss in First Quarter of 2023

Shenzhen Chipscreen Biosciences Co.,Ltd. (深圳微芯生物科技股份有限公司) (688321.SH) reported a net loss of 35.8 million yuan in the first quarter of 2023, widening 858.9% year-on-year.

Meanwhile, the company posted 106.5 million yuan in revenue, up 2% year-on-year.

At the end of the reporting period, it had 3 billion yuan in total assets and 1.4 billion yuan in total liabilities, with a liability-to-asset ratio of 47.7%.